Becotatug for squamous cell carcinoma of head and neck

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 May 2025: Trial registered, NCT06989671

The trials

NCT06989671: SYS6002 Plus JMT101 and Enlonstobart Injection in Participants With HNSCC

State
Not started
Phase
Phase 2
People
430 planned
Started
30 Aug 2025
Primary completion
30 Dec 2027
Arms
JMT101 monotherapy
Results
None posted
  1. 25 May 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as JMT101 Injection.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.